ESGENA Webinars

ESGENA webinars - a step ahead.

Free learning for better endoscopy

ESGENA webinars can help you to get ahead in your professional life. Expand your knowledge and improve your work performance by attending our monthly webinars. Join the discussion via chat and become an active member of the ESGENA community.
The ESGENA webinars covers different responsibilities of endoscopy and gastroenterology nursing:

• Patient care in endoscopy and gastroenterology
• Assistance during procedures and interventions
• Patient and staff safety
• Hygiene and infection control
• Management of units

Thursday, September 24, 2026
18:00–19:30 CET

 

Why Hybrid PEG? Is Pull-Through not Enough?

Exclusively organized with Fresenius Kabi MedTech

 

Agenda

  • Why Hybrid PEG? Is Pull-Through not Enough?
  • How to prevent complications during and after PEG Placement
  • What training is involved, and how is it received?

Speakers

  • Prof. Dr. Christian Borjarski, Germany
  • Ulrike Beilenhoff, Germany

Thursday, October 8, 2026
18:00–19:30 CET

 

 

Foreign Body Removal and a Novel Endoscopic Approach to Weight Loss

Exclusively organized together with Ovesco Endoscopy AG and Erbe Elektromedizin GmbH

 

 

Agenda

  • Two Loops, One Goal: The TandemLoop for Foreign Body Removal (Ovesco Endoscopy AG)
    Christoph Mielke, Germany
  • MOVIVA®: A Novel Endoscopic Approach to Weight Loss (Erbe Elektromedizin GmbH)
    Sebastian Kirking, Germany

Chairs

  • Wendy Carmel, Denmark
  • Marjon de Pater, The Netherlands

Removal of long foreign bodies. Simplified.
The TandemLoop is an instrument designed for the endoscopic removal of elongated foreign bodies from the gastrointestinal tract. As the first instrument to incorporate two independently controllable snares, it enables the alignment and retrieval of elongated foreign bodies using controlled traction. This can reduce the coordination effort previously required to use and switch between multiple instruments for fixation, alignment, and retrieval, as well as the associated need for additional staff.

MOVIVA®- Turn down the food noise
MOVIVA® is the innovative, minimally invasive endoscopic solution for gastric mucosal ablation (GMA) in the fundus. The GMA procedure involves ablating the mucosa of the gastric fundus. This reduces the production of ghrelin - the so-called hunger hormone, resulting in less hunger and fewer cravings. At the same time, the ablation of tissue leads to a shrinking of the fundus. When combined with Endoscopic Sleeve Gastroplasty (ESG), GMA can yield weight loss results comparable to traditional bariatric surgery.

 

Tuesday, October 13, 2026
18:00–19:30 CET

 

 

New Data on Microbiological Surveillance with the Flush-Brush-Flush Method

Exclusively organized together with Olympus Europa SE & Co KG 

 

 

Agenda

  • Literature review - sampling & culturing via Flush-Brush-Flush
    Birgit Kampf, Germany
  • Implementation of the new method and results of a national survey
    Ulrike Beilenhoff, Germany
  • Current evidence on the FBF- technique: Evaluation of channel-integrity and recovery
    Annette Rittich, Germany

Chairs

  • Leigh Donnelly, United Kingdom
  • Camille Dutronc, Switzerland
  • Anastasia Tsalouka, Greece

The Flush-Brush-Flush (FBF) technique is gaining attention as a practical approach to improving microbiological surveillance of flexible endoscopes. But how safe is it, and what does the evidence mean for everyday practice? This webinar will provide a clear, evidence-based overview of FBF, including its potential to improve the recovery of microorganisms and residual contamination while maintaining endoscope channel integrity.

Importantly, the webinar will address current concerns about possible channel damage and share findings from manufacturer testing and clinical experience. Understanding this technique and its background will help support more reliable sampling, better interpretation of microbiological results, and safer, more consistent endoscope reprocessing practices.

Join us to explore what the current evidence tells us—and how FBF may contribute to strengthening microbiological surveillance in your clinical setting.